PTC Therapeutics falls as partner Roche reports Q3 sales for SMA therapy - Seeking Alpha

Retrieved on: 2022-10-18 18:10:02

Tags for this article:

Click the tags to see associated articles and topics

PTC Therapeutics falls as partner Roche reports Q3 sales for SMA therapy - Seeking Alpha. View article details on hiswai:

Excerpt

PTC Therapeutics (PTCT), a biotech focused on rare disorders, traded sharply lower on Tuesday after Roche (RHHBY) (RHHBF), its partner for spinal ...

Article found on: seekingalpha.com